While the studies mentioned above indicate that low GS levels could be beneficial for GBM patients, the only experimental study performed so far showed that overexpression of GS resulted in growth arrest and motility suppression of rat C6 glioma cells in an N-cadherin-dependent manner while GS silencing enhanced cell motility [120]. Here, GLUL is linked to central nervous system cancer.